
Anya Borissova summarises the therapeutic mechanisms of psilocybin in treatment-resistant depression and changes noticed in the amygdala and prefrontal cortex during emotional processing.
[read the full story...]Anya Borissova summarises the therapeutic mechanisms of psilocybin in treatment-resistant depression and changes noticed in the amygdala and prefrontal cortex during emotional processing.
[read the full story...]Vishal Bhavsar reviews a recent study examining correlates of future violent behaviour in people being treated for schizophrenia in US-based treatment centres.
[read the full story...]In her debut blog, Rosa Pitts summarises the ARIES trial, which suggests it may be feasible to use a smartphone app (My Journey 3) to help prevent relapse in psychosis, although questions remain about long-term participant engagement with the app.
[read the full story...]Anton Käll summarises a recent RCT of mindfulness training to reduce loneliness and increase social contact.
Ellie Pearce then shares her recent Wellcome Trust funded #ActiveIngredientsMH review, which looked into reducing loneliness as a potential active ingredient in both alleviating and preventing anxiety and depression in young people.
[read the full story...]In her debut blog, Sophia Ahmed summarises an RCT which finds that Mindfulness based childbirth and parenting can help to reduce stress and depression in expectant mothers.
[read the full story...]Beccy White explores the recently published RESPECT trial – a feasibility RCT which finds that a sexual health promotion intervention was safe and acceptable for people with severe mental illness.
[read the full story...]Aster Daniel summarises a recent study exploring post-traumatic growth after MDMA-assisted psychotherapy for PTSD (post-traumatic stress disorder).
[read the full story...]Masuma Mishu from the Closing the Gap Network reviews a recent US trial of a comprehensive cardiovascular risk reduction intervention in people with severe mental illness, which shows promising results.
[read the full story...]Pascal Immanuel Michael summarises a recent RCT, which looks at how a single dose of the psychedelic Ayahuasca may help people with severe depression who have not benefited from more traditional treatment.
[read the full story...]